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Background: Attention-Deficit/Hyperactivity Disorder (ADHD) in adults is one of the predictive and treatable risk
factors for delinquency, including intimate partner violence (IPV). Effective treatment of IPV needs to address
personal dynamic risk factors, offender typology, and dynamics of the domestic violence. It is unknown whether
treatment of ADHD symptoms contributes to a decrease in IPV. The ITAP study aims to investigate the relationship
between treatment of ADHD symptoms and IPV in patients in forensic mental health care. Moreover, this study
examines the role of comorbid psychopathology, subtype of the offender, and dynamics of the domestic violence.
Methods/Design: The ITAP study is a longitudinal observational study. Participants are followed one year through
various assessments: one before starting treatment (t0), and four during treatment (8, 16, 24 and 52 weeks after
start of the treatment). All participants receive treatment for IPV, ADHD, and comorbid psychopathology, if present.
The primary outcome measure is the change in severity of IPV; the primary predictive variable is the change in
severity of ADHD symptoms. The secondary outcome measure is the observation of the therapist about change in
the offender’s general violent behaviour, within and outside the partner relationship. Data are analysed in a multiple
regression model with change in severity of IPV as the dependent variable and change in severity of ADHD
symptoms as the primary predictor. Other predictive variables taken into account in the analyses are presence of
comorbid psychopathology and personality disorder, subtype of the offender, and dynamics of the domestic
violence. In addition, compliance with treatment and content of the treatment are documented.
Discussion: Research on the treatment process of IPV offenders and victims is complicated by many factors. This
observational design will not allow inferences about causality but may reveal clinically important factors that
contribute to more effective treatment of IPV.
Trial registration: The Netherlands National Trial Register (NTR), trial ID NTR3887.
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The WHO defines domestic violence as “any behaviour
within an intimate relationship that causes physical,
sexual or psychological harm”. Studies about domestic
violence reported a prevalence of nearly 40% in women
who attended general practices [1,2]. In a national survey
in the Netherlands, 9% of the general population reported
severe victimisation of domestic violence in the past
five years, mostly intimate partner violence (IPV) [3].
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unless otherwise stated.committed in the Netherlands. The violence reported
included physical violence in 65% of the cases, sexual
violence in 8% of the cases, and psychological vio-
lence in 28% of the cases. Sixty percent of the victims
were female, whereas 83% of the offenders were male.
The consequences for victims of IPV and children who
witness IPV are severe. In a WHO multi-country study
on women’s health and domestic violence, women who
experienced partner violence reported significantly more
emotional distress, suicidal thoughts, and suicidal attempts
than non-abused women [4]. In a US national sample of
adolescents, the prevalence of parental violence witnessed
was 9%. Having witnessed violence predicted posttraumaticl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and depressive disorder (OR 1.73, CI (95%) 1.11-2.71) [5].
Existing explanatory models about IPV can be divided
into sociocultural, interpersonal, and intrapersonal the-
ories. Sociocultural theories conceptualise IPV as a result
of social structures and culturally determined views on
the role of men and women. The best-known model
within this theory is the Duluth model [6]. Interpersonal
theories focus on different causes of IPV: the learning of
aggressive behaviour by others (modelling and social
learning theory), disturbed attachment patterns (attach-
ment theory), and out-of-control conflicts. Relevant trends
of these theories are the blended behaviour therapy [7],
the emotionally focused therapy [8], and the solution
focused therapy [9]. Intrapersonal theories emphasise the
individual characteristics of the offender, such as here-
ditary factors (temperament), predisposition to anger
and hostility, abuse of alcohol and drugs, and presence of
mental disorders including personality disorders.
In the tradition of the intrapersonal theories, many au-
thors proposed classification of offenders in categories.
Holtzworth-Munroe and Stuart [10,11] suggested an of-
fender typology based on 15 earlier typologies and on
the presence of three dimensions: severity and frequency
of marital violence, generality of violence (family-only
versus extrafamilial violence), and psychopathology of the
offender. They differentiated four subtypes of offenders,
i.e. the overall violent/antisocial type, the dysphoric/bor-
derline type, the slightly antisocial type, and the family-
only/passive aggressive type. Several studies confirmed the
validity of these types by means of cluster analysis [12-15].
Nonetheless, little is known about the inter-rater reliability
and the clinical suitability of these offender types.
As a part of the interpersonal theory, Johnson [16,17]
proposed four patterns of violence: intimate terrorism
(IT), violent resistance (VR), mutual violent control (MVC),
and common couple violence (CCV). These types are
mostly based on the motivation for committing the
violence. IT is defined as systematic violence in a general
pattern of control by one partner over the other, VR as
violence committed by victims against their abusive part-
ners, MVC as violence occurring when both partners act
in a violent manner, and battling for control and CCV as
occasional outbursts of violence from both partners. A
few studies supported the validity of the distinction be-
tween IT and CCV [18-20]. Several articles described the
prevalence of these types being different in distinctive
samples: in the general population the most common type
was CCV; in women’s shelters the most common type was
IT [17,20,21].
The high prevalence of IPV and the severe conse-
quences for victims and children stress the need for ef-
fective treatment. However, two meta-analyses showed
that the overall effectiveness of treatment of partnerviolence is small [22,23]. An explanation for this find-
ing is the heterogeneity of the offenders, victims, and
relationships as well as the fact that most treatment
programmes were not adjusted to this heterogeneity.
According to the Dutch multidisciplinary Guideline
for Domestic Violence [24], the characteristics and psy-
chopathology of the offender must be addressed to make
treatment more effective.
Case control studies comparing IPV offenders to con-
trols revealed some characteristics. Offenders were more
likely to have witnessed parental DV in their families of
origin and were more likely to have been abused as a
child [25]; they had higher scores on narcissistic, anti-
social, schizotypal, and borderline personality traits [26];
and they had more borderline symptoms, more mood
problems, and less self-control [27]. Besides, several pro-
spective studies discovered childhood antisocial behav-
iour, low verbal IQ and low verbal reasoning predictive
for adult IPV [28,29].
Attention-Deficit/Hyperactivity Disorder (ADHD) is
one of the dynamic risk factors for delinquency. Several
studies have shown that impulsivity and hyperactivity in
childhood specifically predict future delinquency, to a
large part, but not only, through the association with
conduct disorder (which is often followed by antisocial
personality disorder (ASPD) in adults) [30-34]. In par-
ticular, ADHD is associated with impulsive or reactive
violent aggression [35]. Some studies have found an as-
sociation between childhood and/or adult ADHD and
adult IPV, sometimes mediated by ASPD [36-40]. Hyper-
activity and impulsivity, as core symptoms of ADHD,
were considered to elevate the risk of aggression, overall
and within intimate relations [36,40,41]. Inattention prob-
lems in itself were found to increase the risk for adult IPV
[36]. This can be explained by the fact that inattention
problems may lead to problems with listening to the other
and perceiving complex social situations, which may in-
crease the risk of interpersonal conflicts. In persons with
poor conflict-handling skills, both problems may increase
the risk of aggression. Besides, ADHD often occurs to-
gether with mood swings, problematic self-regulation and
poor emotion regulation [42]. Self-regulation and emotion
regulation are usually seen as salient qualities to handle
conflicts in an intimate relationship, and consequently,
important to prevent IPV [43]. In addition, the high
comorbidity of ADHD with substance use disorder
and antisocial personality disorder further raises the risk
for delinquency and IPV [44,45].
Prevalence of ADHD in children is 5%, and 3% to 4%
in adolescents and adults [46-49]. Prevalence of ADHD
in forensic mental health care is not known exactly but
might be high, given increased prevalence rates in pris-
oners: 38% in a Dutch study of detainees [50] and 40%
in a Swedish study of inmates [51]. A recently published
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26.2% in adult prison populations [52]. Research in an
outpatient clinic for forensic mental health care in the
Netherlands demonstrated that an ADHD diagnosis in
male adults had been missed very often earlier in life
[53]. Especially prior contacts with the law predicted a
missed diagnosis in the past. The authors hypothesised
that delinquency may mask ADHD and may lead to
overemphasis on all sorts of behaviour problems, and
underestimation of ADHD.
ADHD symptoms can be treated effectively in adults.
The efficacy of stimulants in reducing ADHD symptoms
for adults is well documented in several meta-analyses
[54]. Data from a large Swedish sample of adults with
ADHD recently showed that, among patients with ADHD,
crime rates were lower during periods when they were on
ADHD medication [55]. In addition to drug treatment,
psychological and psychosocial treatments are considered
to be effective interventions for adults with ADHD facing
the demands and responsibilities of adult life [56]. How-
ever, no data are known about the effect of ADHD treat-
ment on rates and severity of IPV.
The ITAP study aims to investigate the impact of
ADHD and its treatment within a comprehensive treat-
ment approach of IPV. The rationale for this study is the
hypothesis that successful treatment of ADHD symptoms,
such as inattention, hyperactivity, impulsivity, and emo-
tional instability, will decrease ADHD symptoms and
lower the risk for and severity of IPV. In addition, the
ITAP study attempts to reveal clinically important factors
that contribute to a more effective treatment of IPV.
Primary and secondary objective of the ITAP study
The primary objective of the ITAP study is to examine
the correlation between change in ADHD symptoms
and change in IPV during a 16-week treatment in forensic
mental health care for offenders of IPV who also meet
criteria of adult ADHD diagnosis.
The secondary objective of the ITAP study is to exam-
ine the correlation between change in ADHD symptoms
and change in indoor and outdoor aggression during a
16-week treatment in forensic mental health care for
offenders of IPV who also meet criteria of ADHD.
In addition, the ITAP study attempts to analyse the
role of potential other predictors of IPV on treatment
outcome, measured at t0, such as: a) severity of ADHD
symptoms, b) severity of borderline personality disorder
problems, c) severity of antisocial personality disorder
problems, d) presence of mood disorder, e) presence of
anxiety disorder, f ) presence of substance use disorder, g)
subtype of the offender according to Holtzworth-Munroe
and Stuart [57], h) dynamics of the domestic violence
according to Johnson [17], and i) compliance with the
treatment.Methods
Study population
Participants are recruited from all patients (men and
women) referred to De Waag Utrecht and De Waag
Amersfoort in the period from October 2012 to December
2015. De Waag is a forensic outpatient clinic in the
Netherlands (locations in Amsterdam, Rotterdam, The
Hague, Leiden, Haarlem, Utrecht, Amersfoort, and Almere).
Patients are referred to De Waag by court, the probation
service, or the primary health care service because of hav-
ing committed an offence. All patients receive information
about the ITAP study at home before intake. The profes-
sional who conducts the intake interview asks patients to
participate and to sign informed consent.
Design
Given existing evidence of effective treatment of ADHD
in adults, it was considered ethically incorrect to con-
duct a randomised controlled trial with a condition in
which ADHD is not treated. Therefore, we chose a lon-
gitudinal observational design with the focus on predic-
tors for successful treatment of IPV. All patients with
recent IPV are asked to participate in the study upon
entry at De Waag. After informed consent, patients are
interviewed by a trained clinician to diagnose possible
adult ADHD or other axis I pathology and axis II path-
ology. Subsequently, those who are diagnosed with adult
ADHD will be included in the study. Next, participants
are followed for a period of one year by way of repeated
assessments: one before (t0) and four during treatment
(at 8, 16, 24 and 52 weeks after start of treatment, respect-
ively). The assessments measure the severity of ADHD
symptoms, IPV and indoor and outdoor aggression. All
participants receive treatment for IPV, ADHD, and other
psychopathology, if present. In addition, compliance with
treatment and content of the treatment is monitored.
Treatment of all participants is based on the Risk
Need Responsivity (RNR) model [58] and matched care.
The treatment for IPV is based on the Dutch Guidelines
for Familial/Domestic Violence in children and adults
[24]. The Guidelines recommend partner-relation and/or
family therapy, treatment of individual psychopathology,
and training in communication skills. In the ITAP study,
treatment of IPV consists of building a safety plan with
the offender, partner, and children, if any, according to
the Signs of Safety method of Turnell [59]. Furthermore,
communication skills are trained according to the method
of Murphy and Eckhardt [60]. The skills training com-
prises putting in time-out and improving communication
and coping skills that are specifically relevant for intimate
partner relations. The training is provided to individuals,
couples, or groups. Treatment for ADHD is based on the
European consensus statement on diagnosis and treat-
ment of adult ADHD [56]. In the ITAP study, treatment
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skills training.
Other psychopathology is treated according to evidence-
based interventions and guidelines. A psychiatrist provides
the drug treatment; a family therapist partner relation
therapy, and a psychologist psycho–education and skills
training.
Ethics statement
The ITAP study is performed in accordance with the
ethical principles laid down in the 1964 Declaration of
Helsinki and subsequent amendments. The study is granted
an exemption from requiring ethics approval by the
medical ethical committee (Commissie Mensgebonden
Onderzoek –CMO- Region Arnhem-Nijmegen).
Registration number 2012/222; NL number 41031.091.12.
Trial registration
The ITAP study is registered at the Netherlands National
Trial Register (NTR), trial ID NTR3887.
Instruments
DIVA 2.0
The structured diagnostic interview for ADHD in adults
2.0 (DIVA 2.0) was first developed in Dutch by J.J.S.
Kooij, MD PhD, psychiatrist, and M.H. Francken, MSc,
psychologist in 2007 [61]. Since October 2010, a slightly
adjusted version with an improved introduction of the
DIVA has been available, DIVA 2.0. The DIVA is freely
available via www.divacenter.eu. The interview allows
a structured assessment of the DSM IV criteria for
ADHD in adulthood and (retrospectively) in childhood. In
addition, the severity of dysfunction due to ADHD symp-
toms is assessed in five areas: work and education, rela-
tionship and family life, social contacts, leisure time, and
self-confidence and self-image. Clinical experience with
ADHD diagnostics is a prerequisite for adequate use of
the interview. Each criterion is scored on the basis of the
information obtained from the patient (if possible, also the
family) and the clinical judgement of the clinician. The
DIVA 2.0 yields both a categorical outcome (ADHD is
present/absent) and a dimensional outcome (the number
of criteria and areas of dysfunction scored). In this
study, a patient is considered to have an ADHD diag-
nosis when at least 6/9 criteria for attention deficit and/or
hyperactivity-impulsivity in childhood and at least 5/9 cri-
teria of attention deficit and/or hyperactivity-impulsivity
in adulthood, and at least 2 areas of dysfunction in child-
hood and adulthood are present (according to DSM-5
[62]). No results are available yet on the psychometric
properties of the DIVA 2.0. However, the interview is used
in many countries, it was used to estimate the preva-
lence of ADHD in older adults in the Netherlands [63],
and – as it is a structured interview based on DSM IV TRcriteria – it is a widely used instrument for diagnosing
ADHD in adults.
PDQ R
The Personality Disorder Questionnaire Revised (PDQ R)
is a screening instrument for DSM-IV-R personality disor-
ders. Sensitivity is high, specificity is low [64]. The PDQ R
yields dimensional scores for the various personality disor-
ders of DSM-IV-R. In this study, the PDQ R is used as a
screening tool prior to the SCID2 interview. The PDQ R
cut-off point per personality disorder is the same as the
required number of criteria according DSM-IV-R per per-
sonality disorder.
SCID2
The Structured Clinical Interview for DSM IV Axis II
diagnoses (SCID2) [65] is a generally accepted and widely
used semi-structured interview for assessing Axis II diag-
noses according to DSM IV. The score on the SCID2 is
both categorical (personality disorder is present/absent)
and dimensional (the number of criteria scored per per-
sonality disorder). Kappa for inter-rater reliability ranged
from .48 - .98 for categorical diagnoses; intra-class cor-
relation coefficients ranged from .90 - .98 for dimensional
assessments; internal consistency coefficients ranged
from .71- .94 [66]. In the ITAP study, only the sections on
the personality disorders with PDQ R scores above cut-off
points will be administered.
MINI plus
The Mini International Neuropsychiatric Interview Plus
(MINI plus) is a structured interview for assessing diag-
noses on Axis I according to DSM IV. Several studies
showed adequate psychometric properties of the MINI
plus [67,68].
ADHD RS for adults, Dutch version
The ADHD DSM-IV Rating Scale (ADHD RS) [69] is a
widely used self-report measure of efficacy in clinical
trials of ADHD treatment in children and adolescents
[70,71]. An adult version was developed and validated at
New York University and used in adult populations with
the purpose of measuring treatment efficacy [72,73].
Goodman et al. [74] found that an improvement of 8–10
points (25%) on the ADHD RS corresponded clinically
with a 1-point improvement on the Clinical Global Im-
pression of Severity (CGI-S), and that an improvement
of 16–20 points (50%) on the ADHD RS corresponded
with a 2-point improvement on the CGI-S.
This study uses the Dutch version of the ADHD RS
for adults. This version contains 23 items. The Dutch
version has good internal consistency (alpha 0.81 – 0.85
for the patient version and 0.83 – 0.88 for the partner
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als to evaluate treatment [76].
CTS2
The Conflict Tactics Scales (CTS) [77] is the most widely
used research method for identifying IPV. The CTS starts
from the premise that conflict is an inevitable aspect of all
human relationships, but that the use of coercion (includ-
ing force and violence) as a conflict-resolution tactic is
harmful. The Revised Conflict Tactic Scales of the CTS
(CTS2) [78] is a self-report questionnaire consisting of 39
items that ask about aspects of behaviour of both the re-
spondent and the partner. The score reflects the frequency
of the behaviour during a certain period. In this study
an eight-week time frame was used to make it pos-
sible to measure any differences through therapy. A
similar approach was followed by Kraanen et al. [79].
The CTS2 consists of five subscales: 1. Physical assault
(score between 0 and 300); 2. Psychological aggression
(score between 0 and 200); 3. Injury (score between 0 and
175); 4. Sexual coercion (score between 0 and 175), and 5.
Negotiation (score between 0 and 150). A limitation of the
CTS2 is that the scales count acts of violence but do not
provide information about the context in which the vio-
lence occurs. The CTS2 also does not measure manipula-
tion involving children, isolation, or intimidation and fails
to detect ongoing systematic patterns of abuse. Despite
these limitations, the CTS2 was chosen as a primary out-
come measure for IPV since there is no better outcome
measure known in literature. Mean scores on the Physical
Assault subscale in a sample of 183 male patients with
alcohol substance abuse and partner violence were 9.4
(SD 15.8, median 4; range 1–129) and mean scores on the
Injury subscale were 6.8 (SD 8.8, median 4, range 1–54)
[80]. In the ITAP study both participants and partners will
fill in the CTS2. Scores are analysed separately and
consistency between the two partners is calculated.
MOAS
The Modified Overt Aggression Scale (MOAS) [81]) is a
measure that describes different forms of aggression in
psychiatric patients. The MOAS consists of four categor-
ies of aggressive behaviour: verbal aggression, physical
violence against objects, physical aggression against one-
self, and physical violence against other people. Each cat-
egory is scored on a four-point scale; the highest score is
the most severe one. The MOAS is scaled by a clinician
on the basis of own clinical observation, information
from the patient, and information from other people. It’s
psychometric properties were studied in a psychiatric
ward in New York; the observation scale proved to be
reliable and valid [81].
For the purpose of this study, we adapted the MOAS to
the subject of partner violence to have a second outcomemeasurement. We left the aggression against oneself out
and we asked about behaviour of indoor and outdoor ag-
gression (verbal, physical and against objects). Because this
version of the MOAS has not been validated for this sam-
ple, we ask both the patient and the therapist to fill in the
questionnaire separately in order to calculate consistency
between self-ratings and therapist-ratings.
Subtype of the offender
Holtzworth-Munroe and Stuart [10,57] differentiated four
subtypes of offenders, i.e. the overall violent/antisocial
type, the dysphoric/borderline type, the slightly antisocial
type, and the family-only/passive aggressive type. Subtype
of the offender is scored by the therapist after the first
three sessions on the basis of all available information. All
therapists are trained to score the subtype of the offender.
In order to increase reliability, the scoring is regularly
discussed in the multidisciplinary team. In addition, part
of the sample is scored simultaneously by trained stu-
dents, in order to calculate inter-observer reliability of this
categorisation.
Dynamics of the domestic violence
Johnson [16], (2004) proposed four patterns of violence:
intimate terrorism, violent resistance, mutual violent
control, and common couple violence. The therapist
scores the dynamics of the domestic violence after the
first three sessions on the basis of all available informa-
tion. All therapists are trained to score the dynamics of
the domestic violence. In order to increase the reliability,
the scoring is regularly discussed in the multidisciplinary
team. In addition, a part of the sample is scored simul-
taneously by trained students, in order to calculate inter-
observer reliability of this categorisation.
Procedure of the ITAP
At t0 all participants fill in ADHD RS, CTS2 client ver-
sion, MOAS client version, and PDQ R. The patient’s
partner is asked to fill in the CTS2 partner version. Sub-
sequently, a trained clinician administers three clinical
interviews, i.e. SCID2, MINI plus and DIVA 2.0 in order
to assess proper diagnoses of Axis I, Axis II, and adult
ADHD. In addition, the treating therapist fills in the
MOAS therapist version and assesses the subtype of the
offender according to Holtzworth-Munroe and Stuart
and the dynamics of the domestic violence according to
Johnson. Only participants with severe IPV and ADHD
diagnosis assessed by DIVA 2.0 (see inclusion criteria)
are included in the ITAP study.
At t1 (8 weeks after start of treatment), t2 (16 weeks
after start of treatment), t3 (24 weeks after start of treat-
ment), and t4 (52 weeks after start of treatment) all partic-
ipants fill in the CTS2 client version, the ADHD RS, and
the MOAS client version. Partners fill in the CTS2 partner
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assess compliance with treatment.
Inclusion criteria of the ITAP study
There are six inclusion criteria for the ITAP study:
1. The participant must be 18 years of age or older.
2. The participant must be decisionally competent and
willing to give informed consent.
3. The participant must have sufficient command of
the Dutch language to fill in questionnaires.
4. The participant must have completed the self-report
questionnaire on IPV in the period of 8 weeks prior
to intake.
5. The severity of the IPV is at least moderate,
operationalised by a score of at least 1 on the
physical assault subscale of the Conflict Tactics Scale
(CTS2), or a score of at least 1 on the injury from
assault subscale of the CTS2, or a score of at least 3
on the psychological aggression subscale of the
CTS2, or a score of at least 2 on the indoor
aggression part of the MOAS.
6. Presence of ADHD diagnosis according to the
DSM-5 as established on the basis of a clinical
assessment: the DIVA.
Exclusion criteria of the ITAP study
Patients with acute severe mental symptoms that require
immediate crisis interventions will be excluded. This is
assessed at the beginning by the professional who con-
ducts the intake interview with the patient and during
treatment by the treating therapist.
Variables
The primary study outcome is the change in severity of
IPV between t0 (before starting treatment) and t2 (after
16 weeks of treatment). The change in IPV is calculated
by the difference in scores on the CTS2 client version
between t0 and t2.
The secondary study outcome is the observation of
the therapist about any change in indoor and outdoor
aggression, determined by the difference in scores on
the MOAS therapist version between t0 and t2.
The primary predictive variable is the change in
ADHD symptoms between t0 and t2, determined by
the difference in scores on the ADHD RS between t0
and t2. Compliance with treatment, as determined by
the number of treatment sessions received at t2, is a
covariate predictor.
Other covariate predictors, scaled at t0 are:
 Severity of ADHD: assessed by the DIVA 2.0;
dimensional score;
 Severity of borderline personality disorder problems,
assessed by the SCID2; dimensional score; Severity of antisocial personality disorder problems,
assessed by the SCID2; dimensional score;
 Presence of mood disorder, assessed by the MINI
plus; categorical score;
 Presence of anxiety disorder, assessed by the MINI
plus; categorical score;
 Presence of substance use disorder, assessed by the
MINI plus; categorical score;
 Subtype of the offender by Holtzworth-Munroe and
Stuart, assessed by structured clinical assessment
by the therapist; categorical score;
 Dynamics of the domestic violence by Johnson,
assessed by structured clinical judgment by the
therapist; categorical score.
Sample size
Data will be analysed in a multiple regression analysis with
change in IPV as dependent variable and change in ADHD
symptoms as primary predictor. Taking alpha = 0.05,
two-sided, a sample size of 131 participants at t2 has
80% statistical power to detect a standardised regression-
coefficient of 0.25. With this sample size, a beta of 0.25
corresponds to an effect size of 0.5, which is considered a
clinically relevant effect. A maximum of 10 predictors is
included in this analysis. Given the target sample, a drop-
out rate of 25% has to be taken into account. This means
that the desired sample size at t0 is 164 participants.
Data analysis
First of all, data will be analysed with SPSS in a multiple
regression analysis with change in IPV at t2 as dependent
variable and change in ADHD symptoms at t2 as primary
predictor. Covariate predictors (compliance with treatment,
severity of ADHD at t0, severity of borderline personality
disorder problems, severity of antisocial personality dis-
order problems, presence of mood disorder at t0, presence
of anxiety disorder at t0, presence of substance use disorder
at t0, subtype of the offender by Holtzworth-Munroe and
Stuart, and dynamics of the domestic violence by Johnson)
will be included in the analysis. The primary analysis is with
completers. Additionally, an intention to treat analysis will
be carried out using the last-observation-carried-forward
method.
Later on, an additional and exploratory analysis will be
carried out in which all time points are examined by
using a multilevel-mixed model approach.
Discussion
The high prevalence of IPV and the severe consequences
for victims and children stress the importance of focusing
on adequate therapy. However, little is known about ef-
fective treatment of IPV. The primary objective of the
ITAP study is to examine the role of ADHD and its treat-
ment within a comprehensive treatment approach of IPV.
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of detecting and treating ADHD as one of the dynamic
risk factors for IPV. Our primary hypothesis is that ADHD
treatment response will lower the risk for IPV. If this
hypothesis is confirmed, this insight may contribute to the
practice of diagnostics and treatment of IPV offenders.
Additionally, the ITAP study examines the presence of
comorbid psychopathology and includes this information
in the analysis. Hence, results of the ITAP study are also
expected to provide more insight into the contribu-
tion of comorbid psychopathology and its interaction
with ADHD to the extent and severity of IPV. Further-
more, the ITAP study is expected to reveal more informa-
tion about the importance of determining offender types,
dynamics of the relationship and, finally, how this know-
ledge will influence the treatment of IPV. Although the
prevalence of these classifications in IPV has been studied
thoroughly, the benefits of these classifications within the
treatment of IPV have never been examined. In most
studies, offender types were determined by cluster analysis
and not by clinical assessment. Little is known about the
reliability of these parameters, when classified by clinicians
for practical use. The inter-rater reliability is presumably
problematic; therefore, data from the ITAP study can also
be used for establishing this reliability.
Exploring the relationship between ADHD and IPV in a
longitudinal design is challenging and research in this field
will have to address several practical and methodological
obstacles. Firstly, as mentioned above, a randomised con-
trolled trial would provide stronger evidence for causality;
however a design in which one group of ADHD patients
is not treated is considered unethical. This observational
design will not allow inferences about causality, but we
hope to detect a strong association between severity of
ADHD symptoms and that of IPV. Secondly, relation-
ships of couples with IPV are usually very unstable.
This may lead to problems with follow-up assessments,
since change in IPV can only be measured if couples have
at least regular contact. For this reason we extended the
CTS2- and MOAS follow up questionnaires with ques-
tions about the actual situation: still living together, not
living together anymore but frequently having contact,
separated but still having contact, and contact with chil-
dren, if any. Thirdly, the drop-out rate in forensic psych-
iatry is generally high and even higher in ADHD patients.
Therefore, in estimating the sample size, a drop-out rate
of 25% was taken into account. Fourthly, forensic patients
tend to have little insight in their behaviour and problems
or are inclined to trivialise it. This may result in lower
scores on t0 self-reports and make it difficult to detect
change. In addition, one of the intended effects of therapy
is to improve self-reflection and self-understanding. Treat-
ment with ADHD medication, for instance, often provides
more insight into problematic behaviour. There is a slightpossibility that this mechanism results in higher scores
on follow up self-reports, such as ADHD RS, CTS2, and
MOAS client version. In that case, a feasible decline of
symptoms or improvement in behaviour is not properly
reflected by the scores on the self-reports. Scores on the
MOAS therapist version and the CTS2 partner version
can meet these objections for the part of the change in
IPV; in the case of a change in ADHD symptoms, it is
harder to overcome these objections.
In spite of this, the ITAP study will provide more
insight into the complex matter of treatment of IPV in
clinical practice and may reveal clinically important fac-
tors that contribute to more effective treatment of IPV.
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